ROR1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ROR1 monoclonal antibodies for advanced research in cancer biology and developmental processes. ROR1 monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ROR1, or receptor tyrosine kinase-like orphan receptor 1, plays a critical role in embryonic development and is implicated in the progression of certain cancers, particularly in hematological malignancies. Its expression is typically restricted to embryonic tissues, making ROR1 a promising target for therapeutic interventions in cancer treatment. Understanding the function and regulation of ROR1 is essential for developing novel strategies to combat malignancies where ROR1 is expressed. Researchers worldwide utilize ROR1 monoclonal antibodies to investigate cellular signaling pathways and molecular mechanisms in cancer development. The specificity and reliability of ROR1 monoclonal antibodies enable precise detection and characterization of ROR1 expression patterns in various experimental settings. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing our understanding of cancer biology and contributing to the development of targeted therapeutic strategies.